Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 17 studies | 61% ± 17% | |
deuterosomal cell | 4 studies | 29% ± 4% | |
erythroblast | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 290.28 | 653 / 653 | 94% | 3.49 | 570 / 605 |
prostate | 99% | 131.96 | 242 / 245 | 87% | 2.11 | 436 / 502 |
breast | 99% | 123.17 | 453 / 459 | 86% | 3.63 | 958 / 1118 |
intestine | 99% | 125.06 | 958 / 966 | 85% | 2.09 | 447 / 527 |
stomach | 94% | 89.99 | 338 / 359 | 89% | 2.33 | 254 / 286 |
kidney | 100% | 242.98 | 89 / 89 | 83% | 2.43 | 746 / 901 |
brain | 95% | 221.36 | 2521 / 2642 | 86% | 3.52 | 603 / 705 |
esophagus | 99% | 110.45 | 1431 / 1445 | 81% | 2.30 | 149 / 183 |
lung | 99% | 236.80 | 575 / 578 | 77% | 2.10 | 894 / 1155 |
pancreas | 93% | 77.91 | 305 / 328 | 83% | 1.83 | 148 / 178 |
bladder | 100% | 89.86 | 21 / 21 | 66% | 1.41 | 333 / 504 |
ovary | 71% | 42.78 | 127 / 180 | 94% | 4.01 | 406 / 430 |
uterus | 98% | 128.28 | 166 / 170 | 53% | 1.33 | 242 / 459 |
adrenal gland | 97% | 121.25 | 249 / 258 | 50% | 0.92 | 116 / 230 |
skin | 94% | 163.98 | 1698 / 1809 | 30% | 0.54 | 143 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.12 | 1 / 1 |
blood vessel | 99% | 141.56 | 1327 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 83.11 | 1161 / 1204 | 0% | 0 | 0 / 0 |
heart | 80% | 55.88 | 689 / 861 | 0% | 0 | 0 / 0 |
spleen | 77% | 41.86 | 186 / 241 | 0% | 0 | 0 / 0 |
liver | 33% | 18.88 | 74 / 226 | 16% | 0.34 | 64 / 406 |
tonsil | 0% | 0 | 0 / 0 | 44% | 0.81 | 20 / 45 |
peripheral blood | 29% | 34.68 | 274 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 0.37 | 22 / 80 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.23 | 4 / 29 |
muscle | 11% | 5.51 | 89 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_0007338 | Biological process | single fertilization |
GO_0007283 | Biological process | spermatogenesis |
GO_0003351 | Biological process | epithelial cilium movement involved in extracellular fluid movement |
GO_0035686 | Cellular component | sperm fibrous sheath |
GO_0031514 | Cellular component | motile cilium |
GO_0005929 | Cellular component | cilium |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0097228 | Cellular component | sperm principal piece |
GO_0005576 | Cellular component | extracellular region |
GO_0043005 | Cellular component | neuron projection |
GO_0005737 | Cellular component | cytoplasm |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SPA17 |
Protein name | Sperm surface protein Sp17 (Sperm autoantigenic protein 17) Sperm surface protein Sp17 (Cancer/testis antigen 22) (CT22) (Sp17-1) (Sperm autoantigenic protein 17) (Sperm protein 17) |
Synonyms | SP17 |
Description | FUNCTION: Sperm surface zona pellucida binding protein. Helps to bind spermatozoa to the zona pellucida with high affinity. Might function in binding zona pellucida and carbohydrates (By similarity). . FUNCTION: Sperm surface zona pellucida binding protein. Helps to bind spermatozoa to the zona pellucida with high affinity. Might function in binding zona pellucida and carbohydrates. . |
Accessions | ENST00000227135.7 ENST00000532692.1 Q05D07 Q15506 |